Fabrication of an In Situ pH-Responsive Raloxifene-Loaded Invasome Hydrogel for Breast Cancer Management: In Vitro and In Vivo Evaluation
Background/Objectives: Raloxifene (RLF) is a therapeutic option for invasive breast cancer because it blocks estrogen receptors selectively. Low solubility, limited targeting, first-pass action, and poor absorption are some of the challenges that make RLF in oral form less effective. This study aime...
Saved in:
Main Authors: | Hanan O. Farouk (Author), Marwa M. Nagib (Author), Amr Gamal Fouad (Author), Demiana M. Naguib (Author), Sherif Faysal Abdelfattah Khalil (Author), Amany Belal (Author), Samar F. Miski (Author), Nisreen Khalid Aref Albezrah (Author), Shatha Hallal Al-Ziyadi (Author), Gi-Hui Kim (Author), Ahmed H. E. Hassan (Author), Kyung-Tae Lee (Author), Doaa S. Hamad (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiarthritic potential of berberine loaded invasomal gel
by: Shweta Jain, et al.
Published: (2022) -
Co‐consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants
by: John D. Clarke, et al.
Published: (2023) -
Design and development of optimal invasomes for transdermal drug delivery using computer program
by: Sureewan Duangjit, et al.
Published: (2016) -
Optimization of Influential Variables in the Development of Buprenorphine and Bupivacaine Loaded Invasome for Dermal Delivery
by: Soraya Babaie, et al.
Published: (2021) -
Smart invasome synthesis, characterizations, pharmaceutical applications, and pharmacokinetic perspective: a review
by: Sopan Nangare, et al.
Published: (2020)